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Aim. To investigate an ability of HBD-2 to induce aggregation of erythrocytes. Methods. 
Aggregation assay, turbidimetry, light microscopy. Results. We have identified aggregation of 
erythrocytes in the presence of at least 12.5 μM HBD-2 that was confirmed by light micros-
copy. Effect was strongly depended on HBD-2 concentration but was masked by hemolysis 
of erythrocytes. Also, aggregation was diminished in presence even 10 mM of NaCl that may 
indicate electrostatic nature of interactions between HBD-2 and erythrocytes. Conclusions. 
HBD-2 can induce the salt-sensitive aggregation of erythrocytes in a dose-dependent manner.
K e y w o r d s: β-defensins, dose-dependent, salt-sensitive
Introduction
HBD-2, a member of the β-defensin family of 
antimicrobial peptides, is an important com-
ponent of innate immunity [1]. Its antimicro-
bial properties rely mainly on the ability to 
bind and permeabilize cell membranes of bac-
teria, viruses and fungi [2]. It also possesses 
some immunomodulatory functions [3]. Some 
of the defensins, such as HNP-2 [4] or cryptdin 
[5], can also induce the formation of peptide-
membrane aggregates after the incubation with 
negatively charged vesicles. For HBD-2 or any 
other β-defensin, this activity has never been 
reported before. So, our goal was to show that 
HBD-2 can aggregate membranes as well. To 
reach the aim erythrocytes were used instead 
of negatively charged vesicles. We also ob-
served some features of this interaction such 
as dose-dependency and salt-sensitivity.
Materials & Methods
Production and purification of recHBD-2. 
HBD-2 was produced by the recombinant 
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E.coli RosettaTM strain transformed by pGEX-
2T-HBD-2 construct as previously de-
scribed [6]. The production of recombinant 
protein was performed in the same way as in 
our previous report [7]. In short, the expression 
of recombinant protein was inducted by addi-
tion of 1 mM IPTG when bacterial growth was 
in the log-phase. After 5 h incubation the bac-
teria were pelleted and lysed. Lysate was ap-
plied on the glutathione-agarose column for 
purification. After washing the column the 
GST-HBD-2 fusion protein was cleaved by 
thrombin and HBD-2 was separated by re-
verse-phase chromatography. The HBD-2 con-
taining fraction was air-dried and analyzed by 
PAAG electrophoresis, densitometry, western-
blot and mass-spectrometry to check quantity, 
purity and conformity with native HBD-2.
Erythrocyte suspension preparation. Blood 
received from healthy volunteers after venipunc-
ture was added to 3.6 % (w/v) sodium citrate 
solution in proportion 9:1. The resulting solution 
was carefully mixed by inverting the tube. 
Erythrocytes were triple washed in 270 mM 
sucrose solution and counted manually. No vis-
ible hemolysis was observed. Afterwards, eryth-
rocytes were diluted to 200 million per milliliter 
of 270 mM sucrose pH 8 or isotonic solution of 
10, 25, 50 and 100 mM NaCl. 
Aggregation assay. Erythrocyte suspension 
was mixed with 3.125, 6.25, 12.5 and 25 μM 
HBD-2. Then 100 μL of each suspension were 
added to the wells of round-bottom 96-well 
plate in triplicate. Plate was incubated at 37 
oC for 60 min and centrifuged at 400 g for 5 
min. After that, the sediment was analyzed. 
Reaction was confirmed negative if sediment 
was dot-shaped and positive if sediment was 
umbrella-shaped. To confirm that the differ-
ences in sediment shape are due to the aggre-
gation of erythrocytes, the samples containing 
25 μM HBD-2 and control sample were care-
fully resuspended and checked by light mi-
croscopy with magnification of 100.8 and 160. 
Turbidity assay. Absorbance measurement 
was performed at 630 nm. This wavelength 
was chosen to eliminate the noise caused by 
hemoglobin absorption that has absorbance 
peak at 580 nm. The change in absorbance 
indicates the changes in turbidity of sample 
due to aggregation or lysis of erythrocytes. 
Before the assay erythrocyte suspensions were 
mixed: 1) with HBD-2 in wide range of con-
centrations from 2.5 to 40 μM for 60 min or 
2) with 20 μM HBD-2 in the presence of 10–
100 mM NaCl for 60 min. Incubation was 
performed at 37 oC in both cases. For checking 
the rate of spontaneous erythrocyte aggrega-
tion and lysis, the control assay was also per-
formed without addition of HBD2.
Statistical method. Standard statistical 
methods were used to process data, which were 
presented in terms of a mean and standard 
deviation. Differences between the groups 
were calculated using U-test, with statistical 
significance of p < 0.05.
Results 
The aggregation assay shows that the addition 
of HBD-2 to erythrocyte suspension leads to 
the changes in erythrocyte sediment shape that 
indicate their aggregation (Table 1). 
Table 1. HBD‑2 induced aggregation 
of erythrocytes
HBD-2 
concentration, μM
0 3.125 6.25 12.5 25
Aggregation - - - + +
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To prove this assumption, the sediments that 
were formed after incubation with 25 μM 
HBD-2 and with intact erythrocytes were ana-
lyzed by light microscopy (Figure 1). The 
analysis shows that HBD-2 induces the forma-
tion of erythrocyte aggregates of different size. 
Most erythrocytes are found in aggregates and 
number of free erythrocytes decreased due to 
the aggregation and hemolysis. 
From Table 1 we can conclude that the ag-
gregates formation may be a dose-dependent 
process because aggregation occurs only if the 
HBD-2 concentration exceeds 12.5 μM. The 
turbidity assay confirms this conclusion 
(Figure 2A). It is remarkable that HBD-2 in 
small amount actually decreases turbidity due 
to strong hemolysis. But when the HBD-2 
concentration exceeds 2.5 μM the aggregation 
rate rapidly increases, at 5 μM reaches pri-
mary turbidity and then increases further to 
20 μM. After that the aggregation stopped and 
additional HBD-2 did not cause more aggrega-
tion.
We also know about the inhibitory effect of 
salts on the HBD-2 activity [1]. To confirm 
that aggregation also depends on the presence 
of salts the turbidity was checked at different 
concentration of NaCl and 20 µM HBD-2 
A
C
B
D
Fig. 1. Microscopic image of HBD-2 induced erythrocyte aggregates: A —intact erythrocytes (160 X); B — intact 
erythrocytes (100.8 X); C —erythrocytes after incubation with 25 μM HBD-2 (160 X); D — erythrocytes after incuba-
tion with 25 μM HBD-2 (100.8 X).
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(Figure 2B). Difference between the values of 
turbidity of control and tested samples was 
insignificant for all NaCl concentrations. 
Therefore, we can conclude that aggregation 
depends on the electrostatic interactions as 
well.
Despite the fact that HBD-2 and some oth-
er defensins can aggregate membranes, an 
explanation of physiological significance of 
this activity may be complicated due to the 
presence of salts in physiological fluids that 
inhibit this activity. On the other side, the ac-
tivity may play a role at the low-salt conditions 
where defensins may aggregate some bacteria 
or enveloped viruses thus enhancing the patho-
gen clearance and preventing their penetration 
into the cells.
Conclusion
The above research allowed us to discover a 
novel mode of action of HBD-2, namely, the 
ability to aggregate erythrocytes, and to dem-
onstrate that this activity is dose-dependent 
and salt-sensitive.
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Мета. Дослідити здатність HBD-2 індукувати агрега-
цію еритроцитів. Методи. Агрегаційний тест, турбі-
диметрія, світлова мікроскопія. Результати. Було ви-
явлено агрегацію еритроцитів в присутності щонай-
менше 12,5 μМ HBD-2, що було підтверджено мікро-
скопічним дослідженням. Ефект сильно залежав від 
концентрації HBD-2, але маскувався за рахунок гемо-
лізу еритроцитів. Також, агрегація пригнічувалась 
навіть у присутності 10 мМ NaCl, що може вказувати 
на електростатичну природу взаємодії HBD-2 та ери-
троцитів. Висновки. HBD-2 здатен індукувати соле-
чутливу агрегацію еритроцитів дозо-залежним чином.
К л юч ов і  с л ов а: β-дефенсини, дозо-залежний, 
соле-чутливий
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Цель. Исследовать способность HBD-2 индуцировать 
агрегацию эритроцитов. Методы. Агрегационный тест, 
турбидиметрия, световая микроскопия. Результаты. 
Было выявлено агрегацию эритроцитов в присутствии 
не меньше 12,5 μМ HBD-2, что было подтверждено 
микроскопическим исследованием. Эффект сильно 
зависел от концентрации HBD-2, но маскировался 
гемолизом эритроцитов. Также, агрегация угнеталась 
в присутствии даже 10 мМ NaCl, что может указывать 
на электростатическую природу взаимодействия меж-
ду HBD-2 и эритроцитами. Выводы. HBD-2 способен 
индуцировать соле-чувствительную агрегацию эри-
троцитов дозо-зависимым образом.
К л юч е в ы е  с л ов а: β-дефенсины, дозо-зависимый, 
соле-чувствительный
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